<p dir="ltr">In two elegant studies, Tyler Jacks’ group and colleagues unveil crucial interactions between dendritic cells and TCF1<sup>+</sup>CD8<sup>+</sup> progenitor T cells, shaping their heterogeneity and offering potential to design new putative cancer immunotherapies and vaccines.</p>
Funding
The authors were supported by Victorian Cancer Agency Fellowship MCRF18027 and National Health and Medical Research Council of Australia Ideas Grant APP1185513 awarded to L.A.M.